Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2018

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Who we help

As the trusted partner to the top 50 global pharmaceutical companies and top 10 contract research organizations, our pharmaceutical data, insights, and analytics are used by businesses operating in all areas of the industry.

Our Specialties

For pharmaceutical companies

Bring game-changing drugs to market more efficiently using our insight and analysis. We’ll help you beat the competition and improve healthcare and patient outcomes.

For contract research organizations

We can help position your organization to win more business and enhance your drug development services. You’ll make better-informed, data-driven decisions while bidding on and implementing clinical trials.

For consultancies

Focus on your clients and expand your business opportunities with Pharma Intelligence. We’ll help you build a complete picture of the fast-changing pharmaceutical market with our insight and expertise.

For marketing agencies

You need to understand and communicate complex information simply and persuasively, often across a variety of channels. We can help with branding, multi-channel communication and more.

For the medtech sector

Your trusted source for industry data, analysis, opinion and news. Access the information you need to inform deal making and business cases for product development and quality control and compliance.

Relevant products

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Standard of care insights

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

Datamonitor Healthcare

HIV Market Growth webinar

By Michael Haydock 26 Apr 2018

Mr. Haydock & Mr. Haas will use the exclusive information within Datamonitor Healthcare and Biomedtracker to present a view of the market for HIV drugs. Informa Pharma Intelligence forecasts HIV sales revenues to increase in the US and five major EU markets to a peak of $22.7bn in 2024 before generic erosion triggers a market decline.

Full video
Scrip

Kaesong Complex A Starting Point For Two Koreas' Healthcare Cooperation

By Jung Won Shin 26 Apr 2018

As political talks gain momentum, the Kaesong Industrial Complex in North Korea could be the starting point of possible healthcare cooperation with the South, once the relationship between the two countries improves, a South Korean official report suggests.

Topic Drug development landscape

View article
Citeline

Industry celebrates at Informa Pharma Intelligence's 3rd Annual CARE Awards

By Doro Shin 26 Apr 2018

The CARE Awards ceremony was held on April 25th at the Boston Harbor Hotel to pay tribute to the people driving the advances in drug development and their commitments to advancing human health. The ceremony was once again hosted by multi-media journalist, Janet Wu, former Anchor and Health Reporter for Boston’s NBC station and adjunct professor at Emerson College

Topic Clinical trials

View article
Scrip

Spotlight On Israel Market Challenges Stunting Biopharma Growth

By Lucie Ellis 24 Apr 2018

Scrip investigates the big issues Israel's biopharma sector need to overcome in order to maintain momentum and achieve sustainable success.

Topic BioPharmaceutical

View article
Scrip

Merck KGaA Down-Plays Further Deals After Consumer Health Sell-Off

By John Davis 20 Apr 2018

The sale of the Merck KGaA consumer health business to Procter & Gamble could eventually give the German multinational greater flexibility in business development activities, but reducing net debt has first claim on the funds.

Topic Business strategies Company analysis

View article
Scrip

TVM Raises White Flag On Biovertis and Morphochem

By Mike Ward 20 Apr 2018

Denoive acquires from TVM Capital both Biovertis and Morphochem, plus a Phase II ready antibiotic asset, for an initial 4% stake worth €900,000. Since their formation, Biovertis and Morphochem have had more than $96m invested in them.

Topic Company analysis Business strategies

View article
Datamonitor Healthcare

Datamonitor Healthcare Podcast 13 April 2018

15 Apr 2018

Zach McLellan, Jack Allen, and guest analyst Michael Ramirez discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the Novartis purchase of AveXis for $8.7 billion as they target gene therapy in SMA.

Topic Company analysis

Full podcast
Biomedtracker

Biomedtracker 2018 Early Outlook Report

13 Apr 2018

What’s on the horizon for pharma in 2018? Find out with Biomedtracker’s Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

Topic Drug development landscape

Single report
Pharmaprojects

Pharmaprojects 2018 Pharma R&D Infographic

By Ian Lloyd 11 Apr 2018

Will the Pharma R&D Annual Review 2018 from Citeline’s Pharmaprojects be music to your ears, or will it sound a sour note? Find out with the Pharma R&D Annual Review 2018 infographic, now available to you as a free download.

Topic Drug development landscape

View infographic
Pharmaprojects

Pharma R&D Annual Review 2018 Supplement

By Ian Lloyd 10 Apr 2018

You’ve already tuned into Pharma R&D Annual Review 2018, the free, music-themed whitepaper from Citeline’s Pharmaprojects. Now, get even more free market data and insights with your download of Pharma R&D Annual Review 2018 Supplement: New Active Substances Launched During 2017.

Topic Drug development landscape

View white paper
Datamonitor Healthcare

Datamonitor Healthcare Podcast 04 April 2018

By Jack Allen 09 Apr 2018

Zach McLellan & Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including analysis on Allogene's announcement that they are in-licensing the TALEN technology from Pfizer to commericalise and develop allogeneic, potentially leading to a strong acceleration of CART therapies.

Topic Drug development landscape

Full podcast
In Vivo

Winners Are Beginning To Emerge In Digital Health: But Without Planning Medtechs Risk Missing The Boat

By Ashley Yeo 08 Apr 2018

The leading medtechs are starting to develop models for providers that show how to implement successful digital strategies, a trend that is serving to put pressure on companies that are yet to make a commitment, says ZS Associates' Pete Masloski.

Topic Digital Health

View article
Scrip

IPO Update: Will Declining Returns Slow Fast Pace Of Biopharma Offerings?

By Mandy Jackson 06 Apr 2018

Offerings by Homology, Unum and Genprex at the end of March brought the first quarter's biopharma IPO total to 14 in the US, putting 2018 on track to beat the 2017 total of 42. But with the average return for this year's IPOs dropping, the pace of offerings could slow.

Topic Company analysis

View article
Scrip

FDA Refuse-To-File Letter For Alkermes Depression Drug Suggests A Lengthy Commercial Delay

By Jessica Merrill 06 Apr 2018

CEO Richard Pops called FDA's letter for ALKS 5461 "surprising and troubling." Alkermes had been ramping up to launch the depression drug later this year, though some investors had remained skeptical.

Topic FDA Drug approval

View article
Datamonitor Healthcare, Biomedtracker

Pharma Intelligence Commercial Solution: Beat Your Competition

05 Apr 2018

To beat your competition, turn to the combined power of Biomedtracker and Datamonitor Healthcare for the most reliable and timely information in the industry.

Topic Drug review

Full video

Latest headlines

Pink Sheet

26 Apr 2018

US FDA Sets 'Low Bar' For Meetings With Patients

Link
Pink Sheet

26 Apr 2018

Celebrex Likely To Get Label Change Saying CV Risk Is Comparable To Ibuprofen, Naproxen

Link
Pink Sheet

26 Apr 2018

CAR-T Reimbursement: Medicare Weighing Bundle For Kymriah, Yescarta In 2019

Link
Scrip

26 Apr 2018

R&D Successes Celebrated At 2018 CARE Awards

Link
Medtech Insight

26 Apr 2018

QUOTED. April 26, 2018. Francine Lane.

Link
Scrip

25 Apr 2018

Kaesong Complex A Starting Point For Two Koreas' Healthcare Cooperation?

Link
Pink Sheet

25 Apr 2018

Volanesorsen, Inotersen And Erenumab Nearing End Of EU Review Process

Link
Scrip

25 Apr 2018

Deal Watch Asia Focus: Pfenex Licenses Asian Rights To Forteo Copy To NT Pharma Group

Link
Pink Sheet

25 Apr 2018

No Safety Shortcuts Under Breakthrough Designation, Synthetic Biologics Finds

Link
Medtech Insight

25 Apr 2018

Allergan Pays $4m In Two Lap-Band Settlements

Link
Medtech Insight

25 Apr 2018

QUOTED. April 25, 2018. Joerg Schickert.

Link
Medtech Insight

25 Apr 2018

EU MDR Software Rules Are Not Being Revised; Will Guidance Help?

Link
In Vivo

25 Apr 2018

Billion Dollar Bets, Health Care Magic

Link
Scrip

25 Apr 2018

Sun Rises For GSK's Trelegy And Shingrix While It Sets For Advair

Link
In Vivo

25 Apr 2018

Business As Usual Is Not A Vision For The Future – The Value-Based Shift Is Underway

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Who we help

Our Specialties

For pharmaceutical companies

For contract research organizations

For consultancies

For marketing agencies

For the medtech sector

Relevant products

Below are the Product Brand List

Trialtrove: gold standard clinical trials intelligence

Datamonitor Healthcare: data analysis and insight

Scrip: industry news and insights

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Report store